.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
AstraZeneca
Baxter
Chubb
Federal Trade Commission
Citi
Argus Health
Queensland Health
Moodys
US Department of Justice

Generated: June 23, 2017

DrugPatentWatch Database Preview

IOBENGUANE SULFATE I 131 Drug Profile

« Back to Dashboard

Which patents cover Iobenguane Sulfate I 131, and what generic Iobenguane Sulfate I 131 alternatives are available?

Iobenguane Sulfate I 131 is a drug marketed by Pharmalucence and is included in one NDA.

The generic ingredient in IOBENGUANE SULFATE I 131 is iobenguane sulfate i-131. Additional details are available on the iobenguane sulfate i-131 profile page.

Summary for Tradename: IOBENGUANE SULFATE I 131

Patents:0
Applicants:1
NDAs:1
Clinical Trials: see list799
Drug Prices:see details
DailyMed Link:IOBENGUANE SULFATE I 131 at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmalucence
IOBENGUANE SULFATE I 131
iobenguane sulfate i-131
INJECTABLE;INJECTION020084-001Mar 25, 1994DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: IOBENGUANE SULFATE I 131

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmalucence
IOBENGUANE SULFATE I 131
iobenguane sulfate i-131
INJECTABLE;INJECTION020084-001Mar 25, 19944,584,187► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Novartis
Harvard Business School
UBS
AstraZeneca
McKesson
Medtronic
Federal Trade Commission
Argus Health
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot